Klockner & Co saw no growth in patent filings and highest growth of 0.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Klockner & Co’s patent filings and grants. Buy the databook here.
Klockner & Co has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent grants with nearly 100% of grants. The World Intellectual Property Organization(WIPO), and United States(US) patent Office are among the top ten patent offices where Klockner & Co is filings its patents. Among the top granted patent authorities, Klockner & Co has 100% of its grants in United States(US).
Safran and RTX could be the strongest competitors for Klockner & Co
Patents related to healthtech and climate change lead Klockner & Co's portfolio
Klockner & Co has the highest number of patents in healthtech followed by, climate change and emissions reduction. For healthtech, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Solar pv related patents lead Klockner & Co portfolio followed by solar thermal, and dental devices
Klockner & Co has highest number of patents in solar pv followed by solar thermal, dental devices, utilities networks.
For comprehensive analysis of Klockner & Co's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.